Cassava Sciences: New Year, Same Game Of Smoke And Mirrors [Seeking Alpha]
Cassava Sciences, Inc. (SAVA)
Last cassava sciences, inc. earnings: 8/12 08:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
The company's research and development expenses increased to $89.4m in 2023. Cassava's CEO remains optimistic about the Phase 3 program of its drug candidate, simufilam, for Alzheimer's disease. Investors will doubtless be familiar with the massive share price swings and battles between shorts and longs that dictate their direction. In this post I recap the history, update on latest developments, and offer some thoughts as to whether simufilam has any chance of meeting endpoints in its 1,000 patient rethink-alz and refocus-alz studies. Rethink data may become available this year. Investment Overview Cassava Sciences, Inc. NASDAQ: SAVA released its full year 2023 earnings and corporate updates on February 28th this year. The company reported $121.1m of cash, and a net loss for the year of $(97.2m), or $(2.32) per share, up from $(76.2m), or $(1.9) per share in the prior year. Research and development expenses were $89.4m, compared to $68m in 2022, and the company forecas
Show less
Read more
Impact Snapshot
Event Time:
SAVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAVA alerts
High impacting Cassava Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
SAVA
News
- Redemption Date Announced for Warrants [Yahoo! Finance]Yahoo! Finance
- Redemption Date Announced for WarrantsGlobeNewswire
- CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the FirmGlobeNewswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVAAccesswire
SAVA
Earnings
- 2/28/24 - Miss
SAVA
Analyst Actions
- 3/5/24 - HC Wainwright
SAVA
Sec Filings
- 4/25/24 - Form 4
- 4/22/24 - Form 4
- 4/17/24 - Form 4
- SAVA's page on the SEC website